Digestive Diseases and Sciences

, Volume 58, Issue 2, pp 574–578 | Cite as

Donor Diabetes Mellitus Is an Independent Risk Factor for Graft Loss in HCV Positive but Not HCV Negative Liver Transplant Recipients

Original Article


Background and Aims

Graft survival in HCV (hepatitis C virus) infected recipients is worse than those transplanted for other liver diseases. We studied whether several donor cardiovascular risk factors (including advanced age, smoking, hypertension, and diabetes mellitus) contribute to worse outcomes for HCV positive and HCV negative liver transplant recipients.


We obtained data from the United Network for Organ Sharing on all adult liver transplants performed in the United States between January 1, 1998 and December 31, 2003. In total, 27,033 transplant cases were evaluated. Independent predictors of graft survival were determined using Cox proportional hazards regression analysis after controlling for factors previously found to be associated with differences in transplant outcomes.


Donor diabetes was a strong independent risk factor for graft failure [hazard ratio (HR) = 1.20, p = 0.006] only in HCV positive recipients. Neither donor smoking status nor hypertension predicted graft loss in either cohort. Consistent with previous studies, advanced donor age, donation after cardiac death, height, and African American donor all predicted graft loss amongst both cohorts.


Accounting for donor diabetes in relation to recipient HCV status in the selection of liver recipients may result in improved graft survival.


Liver transplantation Hepatitis C Liver donor Diabetes mellitus type II 


  1. 1.
    Verna EC, Brown RS Jr. Hepatitis C virus and liver transplantation. Clin Liver Dis. 2006;10(4):919.Google Scholar
  2. 2.
    Berenguer M. Risk of extended criteria donors in hepatitis C virus positive recipients. Liver Transpl. 2008;14:S45–S50.PubMedCrossRefGoogle Scholar
  3. 3.
    Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. 2002;122:889.Google Scholar
  4. 4.
    Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783–790.PubMedCrossRefGoogle Scholar
  5. 5.
    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki–järvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in Type 2 diabetes. Gastroenterology. 2008;135:122–130.Google Scholar
  6. 6.
    Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;306:1356–1362.Google Scholar
  7. 7.
    Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol. 2002;17:1136–1143.PubMedCrossRefGoogle Scholar
  8. 8.
    Evan JL, Goldfine ID, Maddux BA, Grudsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599–622.CrossRefGoogle Scholar
  9. 9.
    Prolisso G, D’Amore A, Volpe C, et al. Evidence for a relationship between oxidative stress and insulin action in noninsulin dependent [type II] diabetic patients. Metabolism. 1994;43:1426–1429.CrossRefGoogle Scholar
  10. 10.
    Nocito A, El-Bardy AM, Clavien PA. When is steatosis too much for transplantation? J Hepatol. 2006;45:494–499.PubMedCrossRefGoogle Scholar
  11. 11.
    Briceno J, Ciria R, Pleguezuelo M, et al. Contribution of marginal donors to liver transplantation for hepatitis C virus infection. Transpl Proc. 2007;39:2297–2299.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of GastroenterologyMassachusetts General HospitalBostonUSA
  2. 2.Division of Gastroenterology and HepatologyStanford UniversityStanfordUSA
  3. 3.Division of GastroenterologySanta Clara Valley Medical CenterSan JoseUSA

Personalised recommendations